We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » MannKind Insulin Inhaler Better Than Standard Treatments: Phase III Results
MannKind Insulin Inhaler Better Than Standard Treatments: Phase III Results
August 16, 2013
MannKind says two Phase III trials of its next generation insulin inhaler showed the device to be significantly better than standard treatments for diabetic patients, providing a potential alternative to shots or drugs.